United States: Mobile Health Apps Continue To Make Headlines

Recently published studies are illustrating the types of issues that mobile health application, or "app," developers will continue to face as the industry matures alongside an evolving regulatory and enforcement landscape.

Study Questions Privacy Policy of Some Mobile Health Apps

Last week, researchers at the Illinois Institute of Technology Chicago-Kent College of Law published a study about the privacy protections of mobile health apps. The study, which analyzed diabetes applications available for download from Google Play (that is, for use on mobile platforms running the Android operating systems), found that over 80% of the diabetes apps had no privacy policies. Further, over 86% of the apps without a privacy policy shared sensitive data with third parties. In addition, nearly 80% of the apps that did have a privacy policy nevertheless shared user information with third parties. Such user information, the researchers note, routinely includes sensitive health information such as insulin and blood glucose levels.  The researchers point out that app developers often sell the information to data aggregation companies, who in turn sell it to credit card issuers, life insurance companies and other third parties.

Study Finds that Some Mobile Health Apps Do Not Function As Advertised

Some app developers are also facing increased scrutiny on a more fundamental issue: the functionality of their apps. Researchers at Johns Hopkins recently found that one of the most popular mobile apps used to measure blood pressure was wrong 8 out of 10 times. The app, called "Instant Blood Pressure," is no longer available for purchase, but users who previously downloaded it are still able to use it. The app measures blood pressure by having the user place their finger over the camera while placing the phone's microphone on their chest. Other apps, including the one below, measure blood pressure through other means:

While some apps like Instant Blood Pressure contained disclaimers that the app was only meant for "Entertainment Purposes," others, including the one pictured above, contain no such disclaimer. Mobile app developers should examine their claims and disclaimers closely, as the failure to properly label and describe the functionality and limitations of an app could lead to potential enforcement measures.

Federal Efforts to Spur Adoption Uncover Limited Reach and Uncertainty Over HIPAA

The growth of mobile health apps is occurring alongside federal government initiatives to spur their adoption. Last year, the federal government announced that it would require electronic health record (EHR) systems to include an application programming interface, or API, in order to be certified under the Meaningful Use program. An API would enable other applications, like mobile medical apps, to interact with the EHR system. According to CMS, the increased use of APIs will:

Enable the development of new functionalities to build bridges across systems and provide increased data access. This will help patients have unprecedented access to their own health records, empowering individuals to make key health decisions.

Patient empowerment is, to be sure, a laudable goal. It is also undisputed that there are potential benefits to mobile health apps. It is less clear, however, how existing law regulates the health and medical app marketplace. Take for example the diabetes apps that sell user data, as identified in the study described above. The primary federal law protecting health information— the Health Insurance Portability and Accountability Act (HIPAA)—applies only to health care providers, health insurers, health care clearinghouses, and the business associates of such entities. So a developer offering a diabetes app on behalf of an insurer would have to abide by HIPAA, but a developer independently offering such apps to the general public would be outside of HIPAA's reach and would not be subject to mandatory patient privacy laws at the federal level. Further complicating matters is the difficulty that the industry has encountered when trying to determine whether HIPAA applies to their particular app product. Fortunately, the U.S. Department of Health and Human Services recently released guidance that analyzes various scenarios involving medical apps and whether HIPAA applies.

Federal Enforcement Paradigm

The issue of non-functioning apps is largely a matter for the Food and Drug Administration (FDA) and the Federal Trade Commission (FTC) to oversee under their respective existing authorities. In 2013, FDA released a 44 page guidance document discussing its approach to regulating mobile medical apps as medical devices under the Food, Drug, and Cosmetic Act (FDCA). In its guidance, FDA outlined the categories of apps that it considers to be subject to regulatory oversight as a medical device. One of these categories corresponds to "mobile apps that transform the mobile platform into a regulated medical device by using attachments, display screens, or sensors or by including functionalities similar to those of currently regulated medical devices." However, FDA also made clear in its guidance that it will exercise enforcement discretion in cases where a medical app poses a low risk to the public.  Jennifer Rodriguez, an agency spokesperson, recently told Wired magazine that:

The FDA is focusing on a small subset of mobile apps that are medical devices and present the greatest risk to patients if they do not work as intended. For that subset, the FDA might take action were it to determine that an app does not meet relevant regulatory requirements. But our typical approach would be to allow a firm to come into compliance voluntarily before taking enforcement action.

The fact that there are hundreds of mobile apps currently being offered on the various app stores without having gone through FDA medical device review indicates that the agency does not currently have the resources to police all market entrants, including those apps that potentially meet the criteria for being regulated as a medical device.  The agency has also been criticized for offering only recommendations for implementing medical device cybersecurity controls rather than mandatory regulations for the industry to follow. This same criticism can apply to the regulation of app-based devices, which suffer from the same potential hacking and malware risks associated with more traditional (but connected) medical devices.

Developers Face Uncertain, Yet Potentially Large Liability

Even though FDA oversight and enforcement resources are presently stretched thin, developers still face potential liability for unsubstantiated, false, or misleading advertising claims under the FTC Act and, as we noted above, for the scope and content of their privacy policies and data sharing activities.  For example, in 2012, Google agreed to pay $22.5 million to settle FTC allegations that that its privacy policies were misleading. In a separate case last year, Google agreed to pay $8.5 million dollars to settle a class action lawsuit accusing it of improperly selling user data. In light of the increased scrutiny of all aspects of mobile health/medical apps—whether from government agencies or consumer-protection advocates—developers of such products should conduct a thorough legal assessment before making their apps available for download.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

In association with
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Check to state you have read and
agree to our Terms and Conditions

Terms & Conditions and Privacy Statement

Mondaq.com (the Website) is owned and managed by Mondaq Ltd and as a user you are granted a non-exclusive, revocable license to access the Website under its terms and conditions of use. Your use of the Website constitutes your agreement to the following terms and conditions of use. Mondaq Ltd may terminate your use of the Website if you are in breach of these terms and conditions or if Mondaq Ltd decides to terminate your license of use for whatever reason.

Use of www.mondaq.com

You may use the Website but are required to register as a user if you wish to read the full text of the content and articles available (the Content). You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these terms & conditions or with the prior written consent of Mondaq Ltd. You may not use electronic or other means to extract details or information about Mondaq.com’s content, users or contributors in order to offer them any services or products which compete directly or indirectly with Mondaq Ltd’s services and products.


Mondaq Ltd and/or its respective suppliers make no representations about the suitability of the information contained in the documents and related graphics published on this server for any purpose. All such documents and related graphics are provided "as is" without warranty of any kind. Mondaq Ltd and/or its respective suppliers hereby disclaim all warranties and conditions with regard to this information, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Mondaq Ltd and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use or performance of information available from this server.

The documents and related graphics published on this server could include technical inaccuracies or typographical errors. Changes are periodically added to the information herein. Mondaq Ltd and/or its respective suppliers may make improvements and/or changes in the product(s) and/or the program(s) described herein at any time.


Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:

  • To allow you to personalize the Mondaq websites you are visiting.
  • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our information providers who provide information free for your use.

Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.

If you do not want us to provide your name and email address you may opt out by clicking here .

If you do not wish to receive any future announcements of products and services offered by Mondaq by clicking here .

Information Collection and Use

We require site users to register with Mondaq (and its affiliate sites) to view the free information on the site. We also collect information from our users at several different points on the websites: this is so that we can customise the sites according to individual usage, provide 'session-aware' functionality, and ensure that content is acquired and developed appropriately. This gives us an overall picture of our user profiles, which in turn shows to our Editorial Contributors the type of person they are reaching by posting articles on Mondaq (and its affiliate sites) – meaning more free content for registered users.

We are only able to provide the material on the Mondaq (and its affiliate sites) site free to site visitors because we can pass on information about the pages that users are viewing and the personal information users provide to us (e.g. email addresses) to reputable contributing firms such as law firms who author those pages. We do not sell or rent information to anyone else other than the authors of those pages, who may change from time to time. Should you wish us not to disclose your details to any of these parties, please tick the box above or tick the box marked "Opt out of Registration Information Disclosure" on the Your Profile page. We and our author organisations may only contact you via email or other means if you allow us to do so. Users can opt out of contact when they register on the site, or send an email to unsubscribe@mondaq.com with “no disclosure” in the subject heading

Mondaq News Alerts

In order to receive Mondaq News Alerts, users have to complete a separate registration form. This is a personalised service where users choose regions and topics of interest and we send it only to those users who have requested it. Users can stop receiving these Alerts by going to the Mondaq News Alerts page and deselecting all interest areas. In the same way users can amend their personal preferences to add or remove subject areas.


A cookie is a small text file written to a user’s hard drive that contains an identifying user number. The cookies do not contain any personal information about users. We use the cookie so users do not have to log in every time they use the service and the cookie will automatically expire if you do not visit the Mondaq website (or its affiliate sites) for 12 months. We also use the cookie to personalise a user's experience of the site (for example to show information specific to a user's region). As the Mondaq sites are fully personalised and cookies are essential to its core technology the site will function unpredictably with browsers that do not support cookies - or where cookies are disabled (in these circumstances we advise you to attempt to locate the information you require elsewhere on the web). However if you are concerned about the presence of a Mondaq cookie on your machine you can also choose to expire the cookie immediately (remove it) by selecting the 'Log Off' menu option as the last thing you do when you use the site.

Some of our business partners may use cookies on our site (for example, advertisers). However, we have no access to or control over these cookies and we are not aware of any at present that do so.

Log Files

We use IP addresses to analyse trends, administer the site, track movement, and gather broad demographic information for aggregate use. IP addresses are not linked to personally identifiable information.


This web site contains links to other sites. Please be aware that Mondaq (or its affiliate sites) are not responsible for the privacy practices of such other sites. We encourage our users to be aware when they leave our site and to read the privacy statements of these third party sites. This privacy statement applies solely to information collected by this Web site.

Surveys & Contests

From time-to-time our site requests information from users via surveys or contests. Participation in these surveys or contests is completely voluntary and the user therefore has a choice whether or not to disclose any information requested. Information requested may include contact information (such as name and delivery address), and demographic information (such as postcode, age level). Contact information will be used to notify the winners and award prizes. Survey information will be used for purposes of monitoring or improving the functionality of the site.


If a user elects to use our referral service for informing a friend about our site, we ask them for the friend’s name and email address. Mondaq stores this information and may contact the friend to invite them to register with Mondaq, but they will not be contacted more than once. The friend may contact Mondaq to request the removal of this information from our database.


This website takes every reasonable precaution to protect our users’ information. When users submit sensitive information via the website, your information is protected using firewalls and other security technology. If you have any questions about the security at our website, you can send an email to webmaster@mondaq.com.

Correcting/Updating Personal Information

If a user’s personally identifiable information changes (such as postcode), or if a user no longer desires our service, we will endeavour to provide a way to correct, update or remove that user’s personal data provided to us. This can usually be done at the “Your Profile” page or by sending an email to EditorialAdvisor@mondaq.com.

Notification of Changes

If we decide to change our Terms & Conditions or Privacy Policy, we will post those changes on our site so our users are always aware of what information we collect, how we use it, and under what circumstances, if any, we disclose it. If at any point we decide to use personally identifiable information in a manner different from that stated at the time it was collected, we will notify users by way of an email. Users will have a choice as to whether or not we use their information in this different manner. We will use information in accordance with the privacy policy under which the information was collected.

How to contact Mondaq

You can contact us with comments or queries at enquiries@mondaq.com.

If for some reason you believe Mondaq Ltd. has not adhered to these principles, please notify us by e-mail at problems@mondaq.com and we will use commercially reasonable efforts to determine and correct the problem promptly.